AI reads brain scans to guide lung cancer treatment
NCT ID NCT07373951
Summary
This study is testing a new artificial intelligence (AI) tool designed to help doctors treat lung cancer that has spread to the brain. The tool analyzes standard brain MRI scans to predict whether a patient's cancer has specific genetic markers (EGFR or ALK), which determine the best treatment. The goal is to provide this information non-invasively, potentially avoiding risky brain surgery just to get a tissue sample for genetic testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.